Global distribution of covid vaccines has begun

FDA FULL APPROVAL
The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. Based on results from the clinical trial, the vaccine was 91% effective in preventing COVID-19 disease.  

Moderna is a Massachusetts-based biotech company working with the NIH. Their vaccine injects snippets of mRNA to mimic COVID.  

Clinical trials in 30,000 people have shown the Moderna vaccine to be 94.1% effective in preventing COVID-19. The Moderna vaccine has been authorized for emergency use by the FDA, and it is currently being distributed to those who are eligible.

Janssen Vaccines in Leiden collaborated with its parent company Janssen Pharmaceuticals in Belgium, a subsidiary of Johnson & Johnson, on producing a viral vector vaccine. When the viral vector enters our body, it produces a harmless part of the virus, called a spike protein, that is found on the surface of the virus that causes COVID-19. Our body recognizes the foreign protein and produces antibodies in response. The vaccine is 66.3% effective in preventing COVID-19 and is 100% effective against COVID-related hospitalization or death. It is currently being distributed to those who are eligible.